Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazole (KET)

Category Primary study
JournalEuropean Journal of Cancer, Supplement
Year 2010
This article has no abstract
Epistemonikos ID: bcede226e192b2b845ed6e6ceb1617917c36a3c5
First added on: Mar 01, 2025